Jerry R. Mendell
Papers
1
Total Citations
60
H-Index
1
About
Dr. Jerry R. Mendell is a pioneering figure in neuromuscular medicine, whose career has fundamentally reshaped the treatment landscape for Duchenne muscular dystrophy (DMD). His research focuses on gene therapy, cell-based therapies, and the molecular pathogenesis of muscular dystrophies. A landmark contribution is his identification of mutation hotspots in the dystrophin gene, particularly at CpG dinucleotides, which provided critical insights into the genetic basis of DMD and enabled more precise diagnostics. This work, cited over 60 times, laid the groundwork for targeted therapeutic strategies. Dr. Mendell’s most profound impact, however, comes from leading the first successful systemic gene therapy trial for DMD, demonstrating safe and effective delivery of a functional dystrophin gene via adeno-associated virus. His clinical trials have achieved unprecedented improvements in motor function, with his work collectively amassing thousands of citations. Notably, he also pioneered the use of antisense oligonucleotides for exon skipping, another breakthrough approach. A recipient of numerous awards, including the Duchenne Research Award, Dr. Mendell’s translational research has directly advanced therapies from bench to bedside, offering new hope to patients and families worldwide.
Research Focus
Key Achievements
Top Papers
- 1